G1 Therapeutics to Present at September Biotech Conferences

RESEARCH TRIANGLE PARK, N.C., Sept. 3, 2015 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that Chief Executive Officer Mark Velleca, MD, PhD, will present at two biotech conferences in September.

22nd Annual NewsMakers in the Biotech Industry
Location: Millennium Broadway Hotel & Conference Center, New York, NY
Presentation date and time: Thursday, September 10 at 3 p.m. EDT
For additional information, please visit: http://www.biocentury.com/conferences/newsmakers/dates.
BioPharm America™ 2015
Location: Boston Marriott Copley Place, Boston, MA
Presentation date and time: Wednesday, September 16 at 3 p.m. EDT
For additional information, please visit: http://www.ebdgroup.com/bpa/index.php.

About G1 Therapeutics, Inc.

G1 Therapeutics, Inc. is a privately held clinical-stage pharmaceutical company based in Research Triangle Park, NC that focuses on the discovery and development of novel, small-molecule therapies to address significant unmet needs in oncology. The company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of best-in-class compounds and first-in-class drug candidates that address two markets: CDK4/6 antineoplastics and protection of the bone marrow and immune system from damage by chemotherapy (chemoprotection).

Visit www.g1therapeutics.com for more information.

CONTACT: Mark Velleca, MD, PhD G1 Therapeutics 919-213-9838 mvelleca@g1therapeutics.com Media: Laura Bagby 6 Degrees Communications 312-448-8098 lbagby@6degreespr.com

Source: G1 Therapeutics